Patricia Garbayo-Salmons

Institute of Research and Innovation Parc Tauli
Country flagSpain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (29)

Pachydermodactyly is a rare and benign acquired digital fibromatosis that can clinically mimic inflammatory arthropathies. We present a case series of three adolescents in whom high‐frequency cutaneous ultrasound was essential for the diagnosis, revealing homogeneous, hypoechoic, and non‐compressible dermal thickening around the proximal interphalangeal joints without evidence of synovitis, tendon involvement, or bone erosions. Ultrasound also enabled objective monitoring of treatment response following intralesional corticosteroid injections in two cases. Cutaneous ultrasound represents a valuable, non‐invasive tool for both the diagnosis and follow‐up of pachydermodactyly, avoiding unnecessary invasive procedures.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background The relationship between hidradenitis suppurativa ( HS) and arthritis is well‐established; however, the impact of their combined disease burden and the associated treatment pattern has not been determined yet. This study aimed to assess disease burden and therapeutic approaches in HS patients with and without arthritis and estimate arthritis prevalence and subtypes. Methods A multicenter, retrospective, case–control study of 272 adults (69 with HS and arthritis; 203 with HS only), drawn from a hospital‐based cohort of 3644 HS patients across 10 Spanish centers. Controls were matched 1:3 by sex, age, and HS duration. Statistical analysis included non‐parametric tests, logistic regression, and linear mixed‐effects models adjusted for confounders. Results HS patients with arthritis had higher rates of immune‐mediated diseases, including inflammatory bowel disease (odds ratio [ OR] 9.44, p < 0.0001) and psoriasis ( OR 2.99, p = 0.0038), higher Dermatology Life Quality Index ( DLQI) scores (6.30 vs. 4.03, p = 0.031), more dermatology visits (7.00 vs. 5.00, p = 0.0077), and greater biologic therapy use (72.07% vs. 39.90%, p < 0.0001). The prevalence of arthritis among HS patients was 1.70% (95% confidence interval [ CI] : 1.00%–2.70%), with spondyloarthritis being the most common subtype (66.6%). Conclusions HS patients with arthritis have a greater disease burden and higher biologic therapy utilization, emphasizing the need for interdisciplinary care and optimizing resources.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (11)

Sebastian Podlipnik

Hospital Clínic de Barcelona

SPAIN
View details

Joan Calvet

Institute of Research and Innovation Parc Tauli

SPAIN
View details

Emili Masferrer i Niubò

Professor associat

Universitat de Vic - Universitat Central de Catalunya

SPAIN
View details

Ricardo Ruiz-Villaverde

Jefe de Servicio

-

SPAIN
View details

Núria Riera-Martí

Institute of Research and Innovation Parc Tauli

SPAIN
View details

Jorge Romaní

-

SPAIN
View details

Júlia Verdaguer-Faja

Universitat Autònoma de Barcelona

SPAIN
View details

Mireia Moreno Martínez-Losa

Institute of Research and Innovation Parc Tauli

SPAIN
View details

Maria Teresa Fernandez-Figueras

Assitant Professor, Head of Department

Universitat Internacional de Catalunya

SPAIN
View details

Alejandro Molina-Leyva

Head of Section

Hospital Universitario Virgen del Rocío

SPAIN
View details

VICENTE EXPÓSITO GIL

AYUNTAMIENTO DE CHIVA

SPAIN
View details